Editorial

New opportunity

The coronavirus pandemic has made people and companies inventive. In March, for example, a school in central Hesse used its 3D printers to produce special hooks to open doors almost contactlessly. Private individuals quickly made their devices available to support the school project.

INDUSTRIAL Production editor-in-chief Andrea Gillhuber. © WBM

The students from Hesse are just one example of numerous projects, private individuals and companies that have used additive manufacturing to quickly provide products and components for hygiene needs and medical devices.

Stratasys, for example, has mobilized its partner network to provide 3D printing resources and expertise. Companies have responded to the call and donated their printing capacities in all regions. Among other things, disposable face shield visors for medical personnel were produced.

And Siemens has made its 3D printing platform Additive Manufacturing Network (AM Network) available for processing design and print requests from doctors, hospitals and medical technology manufacturers. At the same time, the Group has connected its production facilities to print components as required and suitable.

In times when the coronavirus pandemic has caused supply chains to break down, additive manufacturing technology has provided flexibility and agility in the supply of urgently needed components in medical technology. A promising example of the potential of additive manufacturing to disrupt and redesign production processes and supply chains.

Advertisement

Yours, Andrea Gillhuber

Editor-in-Chief

  • Xing Icon
  • LinkedIn Icon
Advertisement
Advertisement

You might also be interested in

Advertisement
Advertisement
Advertisement

3D printing

Stratasys takes over MarkForged

Stratasys is acquiring MarkForged from Nano Dimension for USD 42.5 million, thereby expanding its portfolio in the field of fiber-reinforced composites. The acquisition also strengthens the company's software and materials expertise in industrial 3D...

read more...
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe to our newsletter
Advertisement
Back to home